Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Pharmaceutical Manufacturing
Prestige Biopharma Group is a Pharmaceutical Manufacturing brand in Singapore. Publicly held, at prestigebio.com. Five addresses sit on record, spread over four office countries. It employs 92 people, on the record. It lists vaccines, diagnostics and research and development among its specialties. Its latest round on record is Series unknown, with no amount recorded. It is listed alongside four similar brands, mostly in Biotechnology Research.
Prestige Biopharma (PBP) is an innovative biopharmaceutical company specializing in the discovery and development of innovative biologics and biosimilars. PBP1510 (Ulenistamab) is the First-in-Class Pancreatic Cancer drug which is on the stage of 1/2a global clinical phase. Based on our innovative biomarker, PAUF, we are continuing the challenge for overcoming hard-to-treat diseases such as pancreatic cancer.
We are developing biosimilars to contribute on the patient's drug accessibility. Over 18 biosimilars we have been developing since 2015.
And also, we are expanding the application of PAUF biomarker to the diagnostics. To expand the effectiveness of pancreatic cancer treatment, we are developing the diagnostic device.
The primary focus of current PBP’s R&D is oncology and immune disorders, developing new and similar antibody drugs for solid tumor, pancreatic cancer, and arthritis. In parallel with our efforts to enhance safety, efficacy, and affordability of existing antibody therapeutics, PBP thrives to search for new targets and candidates with a goal to free mankind from devastating diseases
Established on core values cherishing life and fostering the spirit of philanthropy, Prestige BioPharma promises to grow everyday to make our dream come true.
| Countries | 4 |
|---|---|
| Primary country | SG |
All codes: SG AU BE KR
| Rounds | 1 |
|---|---|
| Axis | 2009 to 2026 |
| Series unknown · 1 Feb 2009 | not disclosed |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
92 counted staff profiles at January 2026. The brand's self-reported band sits above that count and is not published as a headcount.
Five addresses on record across 4 countries. Primary: 21 Biopolis Road, #04-24/28 Nucleos South Building, Singapore 138567.
One round. Latest 1 February 2009: Series unknown, no amount recorded.
13 tags on the brand's own list, among them vaccines, diagnostics and research and development.
16 profiles list Prestige Biopharma Group (Prestige Biopharma / Prestige Biologics) as a peer — 92nd percentile in Pharmaceutical Manufacturing. It lists ten peers of its own. Hummingbird Bioscience and Tessa Therapeutics Ltd list it back.